Target Name: EXOG
NCBI ID: G9941
Review Report on EXOG Target / Biomarker Content of Review Report on EXOG Target / Biomarker
EXOG
Other Name(s): exo/endonuclease G | Nuclease EXOG, mitochondrial (isoform 1) | endonuclease G-like 2 | ENGL-b | endo G-like 1 | Endonuclease G-like 1 | ENGL | ENGLB | nuclease EXOG, mitochondrial | EXOG variant 1 |

EXOG: A Protein Involved in DNA Replication, Repair and Signaling Pathways

EXOG (Exo/Endonuclease G) is a protein that is expressed in various cell types, including bacteria, archaea, and eukaryotes. It is a member of the nucleotide-binding oligomerization domain (NBO domain) family, which is characterized by the presence of a nucleotide-binding domain and a characteristic oligomerization-like structure.

EXOG is involved in a variety of cellular processes, including DNA replication, transcription, and DNA damage repair. It is a critical regulator of DNA synthesis, and is required for the proper functioning of many cellular processes.

One of the unique features of EXOG is its ability to interact with DNA in a highly specific and efficient manner. EXOG has been shown to interact with DNA in a process known as \"endonuclease G-mediated DNA double-strand break repair,\" which involves the cleavage of a double-stranded DNA break by the enzyme G.

EXOG is also involved in the regulation of DNA replication, as well as DNA transcription and repair. In addition, EXOG has been shown to play a role in the regulation of gene expression, and is has been shown to interact with proteins that are involved in the regulation of gene expression.

EXOG has also been shown to be involved in the regulation of cellular signaling pathways, including the DNA damage repair pathway. In addition, EXOG has been shown to play a role in the regulation of cellular apoptosis, as well as the regulation of cellular immortality.

In addition to its role in cellular signaling pathways, EXOG is also of interest as a potential drug target.EXOG has been shown to interact with a variety of small molecules, including inhibitors of DNA synthesis, and may be a useful target for the development of new drugs for a variety of cellular processes, including cancer, infection, and inflammation.

EXOG is also of interest as a potential biomarker for a variety of diseases. Its ability to interact with DNA in a specific and efficient manner may make it an useful tool for the diagnosis and treatment of genetic disorders, as well as for the screening of new therapeutic targets.

In conclusion, EXOG is a protein that is expressed in a variety of cell types and is involved in a number of cellular processes, including DNA replication, transcription, and repair, as well as signaling pathways and apoptosis. Its unique ability to interact with DNA in a specific and efficient manner makes it a potential drug target and a useful biomarker for a variety of diseases. Further research is needed to fully understand the role of EXOG in cellular processes and its potential as a drug target and biomarker.

Protein Name: Exo/endonuclease G

Functions: Endo/exonuclease with nicking activity towards supercoiled DNA, a preference for single-stranded DNA and 5'-3' exonuclease activity

The "EXOG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EXOG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

EXOGP1 | Exon junction complex | EXOSC1 | EXOSC10 | EXOSC10-AS1 | EXOSC2 | EXOSC3 | EXOSC4 | EXOSC5 | EXOSC6 | EXOSC7 | EXOSC8 | EXOSC9 | Exosome Complex | EXPH5 | EXT1 | EXT2 | EXTL1 | EXTL2 | EXTL2P1 | EXTL3 | EXTL3-AS1 | EYA1 | EYA2 | EYA3 | EYA4 | EYS | EZH1 | EZH2 | EZHIP | EZR | F10 | F11 | F11-AS1 | F11R | F12 | F13A1 | F13B | F2 | F2R | F2RL1 | F2RL2 | F2RL3 | F3 | F5 | F7 | F8 | F8A1 | F8A2 | F8A3 | F9 | FA2H | FAAH | FAAH2 | FAAHP1 | FAAP100 | FAAP20 | FAAP24 | FABP1 | FABP12 | FABP2 | FABP3 | FABP4 | FABP5 | FABP5P1 | FABP5P10 | FABP5P11 | FABP5P2 | FABP5P3 | FABP5P7 | FABP6 | FABP7 | FABP7P1 | FABP9 | FACT complex | FADD | FADS1 | FADS2 | FADS2B | FADS3 | FADS6 | FAF1 | FAF2 | FAH | FAHD1 | FAHD2A | FAHD2B | FAHD2CP | FAIM | FAIM2 | FALEC | FAM104A | FAM104B | FAM106A | FAM106C | FAM107A | FAM107B | FAM110A | FAM110B | FAM110C